Biocon to Acquire $198.5 Mn OCDs in Biocon Biologics—Strengthens Control & Balance Sheet

Unknown Apr 02, 2026 700 Views

Biocon Ltd. has announced its decision to purchase 25 optionally convertible debentures (OCDs) of its subsidiary Biocon Biologics Ltd. for a total consideration of $198.5 million. The move is part of a broader capital restructuring strategy aimed at consolidating ownership and streamlining financ...